Thank you for sharing!

Your article was successfully shared with the contacts you provided.
The new FDA initiative is meant to clear that backlog, speeding competition and the subsequent price drops. (Photo: Shutterstock)

Makers of copycat drugs will face pressure to bring down prices even more quickly as the U.S. Food and Drug Administration pushes to get more low-cost competition to market.


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.